Newsroom

Are you watching Optimum TV?

#71

#70

#69

#68

#67

#66

#65

#64

#63

#62

#62

#61

#60

#59

#58

#57

#56

#55

#54

#53

#52

#51

#50

#49

#48

#47

#46

#45

#44

#43

#42

#41

#40

#40

#39

#38

#37

#37

#36

#35

#34

#33

#32

#31

#30

#29

#28

#27

#26

#25

#25

#24

#23

#22

#21

#20

#19

#18

#17

#16

#15

#14

#13

#12

#11

#10

#9

#8

#7

#6

#5

#4

#3

#2

#1

Recent news

Optimum Strategic Communications to Host 16th Annual Healthcare Investor Conference with ‘Back to Growth’ theme

Weekly wrap-up: $100m Series B financing for a bivalent vaccine, to new clinical data from a cutting-edge antibody-drug conjugate…

Weekly round-up: From a vaccine protein manufacturing collaboration, to the appointment of an orthopaedic devices expert…

Weekly round-up: Looking ahead to a busy autumn 2024

Check out Optimum’s podcasts this summer

Weekly wrap-up: Novo Holdings leads $105 million financing of Magenta Medical to support FDA approval for world’s smallest heart pump

Asceneuron secures $100m Series C financing to progress neurodegeneration research, Novo Holding leads round with participation from existing investor Sofinnova Partners

We’d love to hear from you.

For more information about Optimum Strategic Communications, please get in touch.

© Optimum Strategic Communications.